Boston Scientific (BSX) Leases (2019 - 2026)

Boston Scientific's Leases history runs 8 years deep, the most recent figure standing at $547.0 million for Q1 2026.

• In Q1 2026, Leases rose 22.1% year-over-year to $547.0 million; the TTM figure through Mar 2026 stood at $547.0 million (up 22.1% YoY), while the FY2025 annual figure was $465.0 million, up 3.56% from the prior year.
• Leases came in at $547.0 million for Q1 2026 at Boston Scientific, up from $465.0 million in the prior quarter.
• In the past five years, Leases ranged from a high of $547.0 million in Q1 2026 to a low of $386.0 million in Q4 2022.
• A 5-year average of $440.9 million and a median of $439.0 million in 2023 frame the typical range for Leases.
• Across the five-year window, Leases retreated 11.26% in 2022 and advanced 22.1% in 2026, its largest moves.
• Boston Scientific's Leases stood at $386.0 million in 2022, then increased by 13.73% to $439.0 million in 2023, then climbed by 2.28% to $449.0 million in 2024, then advanced by 3.56% to $465.0 million in 2025, then rose by 17.63% to $547.0 million in 2026.
• According to Business Quant data, Leases over the past three periods registered $547.0 million, $465.0 million, and $495.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison